Given that most human tumours contain either integrins αVβ3, nucleolin, or both of these markers on their surface, it is conceivable that a radiopharmaceutical based on E1b protein or its derivatives could be a rather versatile tool for primary cancer diagnosis by SPECT/CT. The gene discussed is NUCLEOLIN; the disease is cancer.